MRNA - Moderna Likely To Report Q4 Loss; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts | Benzinga
Moderna, Inc. (NASDAQ: MRNA) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 22, 2024.
Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at 97 cents per share, versus year-ago earnings of $3.61 per share. Moderna is projected to report quarterly revenue of $2.5 billion, compared to $5.08 billion in the year-earlier quarter, according to data from Benzinga Pro.
Moderna, last month, announced a series of business updates and progress on the company’s pipeline of mRNA medicines at the 42nd annual JPMorgan Healthcare Conference. The company said it came into 2024 with 45 total therapeutic and vaccine programs. Nine of those programs are in late-stage development.
Moderna shares rose 0.7% to close ...